Is Kindred Biosciences (KIN) A Good Stock To Buy Now?
Many prominent investors, including Warren Buffett, David Tepper and Stan Druckenmiller, have been cautious regarding the current bull market and missed...
Posts Tagged ‘NASDAQ:KIN’
Hedge Funds Cautiously Watching Kindred Biosciences Inc (KIN)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data....
Is Kindred Biosciences Inc (KIN) A Good Stock To Buy?
Before we spend days researching a stock idea we like to take a look at how hedge funds and billionaire investors recently traded that stock. Russell...
Here’s What Hedge Funds Think About Kindred Biosciences Inc (KIN)
Like everyone else, elite investors make mistakes. Some of their top consensus picks, such as Amazon, Facebook and Alibaba, have not done well in Q4 due...
13G Filing: Ariel Investments and Kindred Biosciences Inc. (KIN)
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 1 – SEC Filing UNITED STATES SECURITIES AND EXCHANGE...
Should You Buy Kindred Biosciences Inc (KIN)?
Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals. They...
Kindred Biosciences, Inc. (KIN): Hedge Funds and Value Investors Are Crazy About It
Kindred Biosciences Inc (NASDAQ:KIN) is a tiny stock, yet managed to attract high profile hedge funds and value investors. Famed value investor Seth Klarman...
Is Kindred Biosciences Inc (KIN) Going to Burn These Hedge Funds?
Many investors, including Carl Icahn or Stan Druckenmiller, have been saying for a while now that the current market is overvalued due to a low interest...
Billionaire Seth Klarman’s Top 3 Micro-Cap Stock Picks ~ Bellatrix Exploration Ltd (BXE), Kindred Biosciences Inc (KIN) and Alliance One International, Inc. (AOI)
The world’s 11th largest hedge fund, Seth Klarman’s Baupost Group, recently filed its 13F with the Securities and Exchange Commission for the end...
Seth Klarman’s Baupost Group Initiates Stake in Kindred Biosciences Inc (KIN); Trims Holding in Enzon Pharmaceuticals Inc (ENZN)
In two filings with the Securities and Exchange Commission, Baupost Group, a hedge fund managed by Seth Klarman, disclosed reducing its position in...
